Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Jun Kim

Showing results (171-180 of 425) with videos related to

Pageof 43
Sort By:
Acta Pharmaceutica Sinica. B|December 30, 2015
Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43Yuri Cho, Jung-Hwan Yoon, Jeong-Ju Yoo, et al.
Scientific Reports|February 17, 2025
Metabolic dysfunction-associated steatotic liver disease increases cardiovascular disease risk in young adultsGoh Eun Chung, Su Jong Yu, Jeong-Ju Yoo, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2023
Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non-cirrhotic patients with chronic hepatitis BCheol-Hyung Lee, Yun Bin Lee, Hyemi Moon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 29, 2009
Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graftNam-Joon Yi, Kyung-Suk Suh, Hae Won Lee, et al.
Cancer Communications (London, England)|June 20, 2023
Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjectsGoh Eun Chung, Su Jong Yu, Jeong-Ju Yoo, et al.
Digestive Diseases (Basel, Switzerland)|August 11, 2011
TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrenceJeong-Hyun Kim, Su Jong Yu, Byung-Lae Park, et al.
Plos One|May 6, 2016
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score AnalysisYoung Youn Cho, Minjong Lee, Hyo-Cheol Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2015
Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver DiseaseDonghee Kim, Goh Eun Chung, Min-Sun Kwak, et al.
European Radiology|August 13, 2016
Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombusJin Woo Choi, Hyo-Cheol Kim, Jeong-Hoon Lee, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2012
Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseasesJoon Seol Bae, Jeong-Hyun Kim, Charisse Flerida A Pasaje, et al.
Pageof 43

Showing results (171-180 of 425) with videos related to

Sort By:
Pageof 43
Acta Pharmaceutica Sinica. B|December 30, 2015
Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43Yuri Cho, Jung-Hwan Yoon, Jeong-Ju Yoo, et al.
Scientific Reports|February 17, 2025
Metabolic dysfunction-associated steatotic liver disease increases cardiovascular disease risk in young adultsGoh Eun Chung, Su Jong Yu, Jeong-Ju Yoo, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2023
Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non-cirrhotic patients with chronic hepatitis BCheol-Hyung Lee, Yun Bin Lee, Hyemi Moon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 29, 2009
Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graftNam-Joon Yi, Kyung-Suk Suh, Hae Won Lee, et al.
Cancer Communications (London, England)|June 20, 2023
Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjectsGoh Eun Chung, Su Jong Yu, Jeong-Ju Yoo, et al.
Digestive Diseases (Basel, Switzerland)|August 11, 2011
TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrenceJeong-Hyun Kim, Su Jong Yu, Byung-Lae Park, et al.
Plos One|May 6, 2016
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score AnalysisYoung Youn Cho, Minjong Lee, Hyo-Cheol Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2015
Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver DiseaseDonghee Kim, Goh Eun Chung, Min-Sun Kwak, et al.
European Radiology|August 13, 2016
Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombusJin Woo Choi, Hyo-Cheol Kim, Jeong-Hoon Lee, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2012
Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseasesJoon Seol Bae, Jeong-Hyun Kim, Charisse Flerida A Pasaje, et al.
Pageof 43